Background Guidelines recommend individualization of dual antiplatelet therapy (DAPT)
duration. Whether to guide decisions based on bleeding risk, ischemic risk or a combination …

The originally-proposed PRECISE-DAPT score is a 5-item risk score supporting decision-
making for dual antiplatelet therapy 1 duration after PCI. It is unknown if a simplified version …

Background Dual antiplatelet therapy (DAPT) is the standard of care following PCI. DAPT
reduces ischemic events but increases bleeding risk. Duration of DAPT following PCI …

Purpose of review The optimal duration of dual antiplatelet therapy (DAPT) has been a topic
of considerable interest in recent years, as the risk of stent thrombosis has decreased with …

After 15 trials and more than 40,000 patients cumulatively randomized, determining the
optimal duration of dual antiplatelet therapy (DAPT) for individual patients undergoing …

Dual antiplatelet therapy (DAPT) is a pillar for the prevention of cardiovascular events
following acute coronary syndromes and/or percutaneous coronary intervention (PCI)(1, 2) …

Background The dual antiplatelet therapy (DAPT) score, one of the first prediction tools to
attempt to uncouple bleeding and ischemic risk following percutaneous coronary …

The benefits and harms of dual antiplatelet therapy (DAPT) continuation with aspirin and
clopidogrel beyond 1 year after percutaneous coronary intervention (PCI) with drug-eluting …

Background: The dual antiplatelet therapy (DAPT) risk score was developed from the DAPT
trial to inform the optimal duration of DAPT after percutaneous coronary intervention. We …

The optimal length of dual antiplatelet therapy (DAPT) after percutaneous coronary
intervention (PCI) remains debated. Current guidelines recommend individualized treatment …